BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31793629)

  • 1. Therapeutic Mechanism of Macrophage Inflammatory Protein 1 α Neutralizing Antibody (CCL3) in Clostridium difficile Infection in Mice.
    Wang J; Ortiz C; Fontenot L; Mukhopadhyay R; Xie Y; Chen X; Feng H; Pothoulakis C; Koon HW
    J Infect Dis; 2020 Apr; 221(10):1623-1635. PubMed ID: 31793629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expression.
    Coffing H; Priyamvada S; Anbazhagan AN; Salibay C; Engevik M; Versalovic J; Yacyshyn MB; Yacyshyn B; Tyagi S; Saksena S; Gill RK; Alrefai WA; Dudeja PK
    Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G43-G52. PubMed ID: 29597352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fidaxomicin inhibits Clostridium difficile toxin A-mediated enteritis in the mouse ileum.
    Koon HW; Ho S; Hing TC; Cheng M; Chen X; Ichikawa Y; Kelly CP; Pothoulakis C
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4642-50. PubMed ID: 24890583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human monoclonal antibodies against Clostridium difficile toxins A and B inhibit inflammatory and histologic responses to the toxins in human colon and peripheral blood monocytes.
    Koon HW; Shih DQ; Hing TC; Yoo JH; Ho S; Chen X; Kelly CP; Targan SR; Pothoulakis C
    Antimicrob Agents Chemother; 2013 Jul; 57(7):3214-23. PubMed ID: 23629713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fidaxomicin and OP-1118 Inhibit Clostridium difficile Toxin A- and B-Mediated Inflammatory Responses via Inhibition of NF-κB Activity.
    Koon HW; Wang J; Mussatto CC; Ortiz C; Lee EC; Tran DH; Chen X; Kelly CP; Pothoulakis C
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038278
    [No Abstract]   [Full Text] [Related]  

  • 6. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
    Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
    Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100B Inhibition Attenuates Intestinal Damage and Diarrhea Severity During
    Costa DVS; Moura-Neto V; Bolick DT; Guerrant RL; Fawad JA; Shin JH; Medeiros PHQS; Ledwaba SE; Kolling GL; Martins CS; Venkataraman V; Warren CA; Brito GAC
    Front Cell Infect Microbiol; 2021; 11():739874. PubMed ID: 34568098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loratadine is an anti-inflammatory agent against C. difficile toxin B.
    Xie Y; Irwin S; Chupina Estrada A; Nelson B; Bullock A; Fontenot L; Feng H; Sun M; Koon HW
    J Infect Dis; 2024 Jan; ():. PubMed ID: 38243838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression and polarized secretion of CXC and CC chemokines by human intestinal epithelial cancer cell lines in response to Clostridium difficile toxin A.
    Kim JM; Kim JS; Jun HC; Oh YK; Song IS; Kim CY
    Microbiol Immunol; 2002; 46(5):333-42. PubMed ID: 12139393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic deficiency in the chemokine receptor CCR1 protects against acute Clostridium difficile toxin A enteritis in mice.
    Morteau O; Castagliuolo I; Mykoniatis A; Zacks J; Wlk M; Lu B; Pothoulakis C; Gerard NP; Gerard C
    Gastroenterology; 2002 Mar; 122(3):725-33. PubMed ID: 11875005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-toxin antibody is not associated with recurrent Clostridium difficile infection.
    Gilbert J; Leslie J; Putler R; Weiner S; Standke A; Penkevich A; Keidan M; Young VB; Rao K
    Anaerobe; 2021 Feb; 67():102299. PubMed ID: 33227427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic dissemination of Clostridium difficile toxins A and B is associated with severe, fatal disease in animal models.
    Steele J; Chen K; Sun X; Zhang Y; Wang H; Tzipori S; Feng H
    J Infect Dis; 2012 Feb; 205(3):384-91. PubMed ID: 22147798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
    Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxin-mediated paracellular transport of antitoxin antibodies facilitates protection against Clostridium difficile infection.
    Zhang Z; Chen X; Hernandez LD; Lipari P; Flattery A; Chen SC; Kramer S; Polishook JD; Racine F; Cape H; Kelly CP; Therien AG
    Infect Immun; 2015 Jan; 83(1):405-16. PubMed ID: 25385797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium difficile toxin A and toxin B inhibit YAP in the colonic epithelial cells.
    Song J; Shen X; Huang Z; Liu Y; Cui L; Cui X; Liu CY
    J Biochem Mol Toxicol; 2021 Feb; 35(2):e22652. PubMed ID: 33251692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stool Interleukin-1β Differentiates Clostridioides difficile Infection (CDI) From Asymptomatic Carriage and Non-CDI Diarrhea.
    Villafuerte Gálvez JA; Pollock NR; Alonso CD; Chen X; Xu H; Wang L; White N; Banz A; Miller M; Daugherty K; Gonzalez-Luna AJ; Barrett C; Sprague R; Garey KW; Kelly CP
    Clin Infect Dis; 2023 Feb; 76(3):e1467-e1475. PubMed ID: 35906836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D
    Chan H; Li Q; Wang X; Liu WY; Hu W; Zeng J; Xie C; Kwong TNY; Ho IHT; Liu X; Chen H; Yu J; Ko H; Chan RCY; Ip M; Gin T; Cheng ASL; Zhang L; Chan MTV; Wong SH; Wu WKK
    Autophagy; 2022 Sep; 18(9):2050-2067. PubMed ID: 34989311
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary human colonic myofibroblasts are resistant to Clostridium difficile toxin A-induced, but not toxin B-induced, cell death.
    Mullan N; Hughes KR; Mahida YR
    Infect Immun; 2011 Apr; 79(4):1623-30. PubMed ID: 21245273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of Nuclear Factor-κB by Tumor Necrosis Factor in Intestinal Epithelial Cells and Mouse Intestinal Epithelia Reduces Expression of the Chloride Transporter SLC26A3.
    Kumar A; Chatterjee I; Gujral T; Alakkam A; Coffing H; Anbazhagan AN; Borthakur A; Saksena S; Gill RK; Alrefai WA; Dudeja PK
    Gastroenterology; 2017 Nov; 153(5):1338-1350.e3. PubMed ID: 28823863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clostridium difficile-derived membrane vesicles induce the expression of pro-inflammatory cytokine genes and cytotoxicity in colonic epithelial cells in vitro.
    Nicholas A; Jeon H; Selasi GN; Na SH; Kwon HI; Kim YJ; Choi CW; Kim SI; Lee JC
    Microb Pathog; 2017 Jun; 107():6-11. PubMed ID: 28284851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.